Status:
WITHDRAWN
Fever and Neutropenia in Pediatric Oncology Patients
Lead Sponsor:
University of Colorado, Denver
Conditions:
Fever
Neutropenia
Eligibility:
All Genders
Up to 21 years
Phase:
PHASE3
Brief Summary
It is possible to distinguish between pediatric oncology patients who are at high or low risk for serious infection during periods of fever and treatment related neutropenia based on clinical paramete...
Detailed Description
Outpatient management of patients considered to be at low risk for serious bacterial infection has been explored using risk stratification schema based on clinical parameters. First, patients will be ...
Eligibility Criteria
Inclusion
- 1\. Any pediatric patient age \<21 years with an oncology diagnosis who is undergoing therapy and is expected to have treatment related neutropenia.
Exclusion
- Any patient who has previously undergone autologous or allogeneic bone marrow transplant will be excluded from study enrollment. If a patient is expected to undergo autologous or allogeneic bone marrow transplant as part of therapy at some point after enrollment in the study he/she will be removed from the study at the start of their bone marrow transplant.
- Any patient with a documented allergy to Levofloxacin or any other fluoroquinolone will be excluded.
- Patients with a known pregnancy will be excluded.
- Any patient with an underlying chronic musculoskeletal condition (ie Juvenile rheumatoid arthritis, Systemic lupus erythematosis etc) which may make evaluation for joint toxicity related to quinolone treatment difficult.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03768869
Start Date
February 1 2006
End Date
April 3 2009
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045